Reaction
Sarcoma reporting signals
As of the last recalculation, Sarcoma appears in 1,118 FAERS reports alongside 12 co-occurring drug terms. The strongest observed disproportionality signal is PAZOPANIB HYDROCHLORIDE (PRR 34.5).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Pazopanib Hydrochloride | 48 | 34.5 | 34.5 |
| Selinexor | 11 | 23.9 | 23.9 |
| Ifosfamide | 24 | 21.2 | 21.3 |
| Mesna Injection | 8 | 18.1 | 18.2 |
| Mesna | 8 | 17.8 | 17.8 |
| Doxorubicin Hydrochloride | 16 | 9.2 | 9.2 |
| Doxorubicin | 42 | 9.1 | 9.1 |
| Gemcitabine | 17 | 8.1 | 8.1 |
| Acalabrutinib | 5 | 7.7 | 7.7 |
| Crizotinib | 5 | 7.4 | 7.4 |
| Docetaxel Anhydrous | 23 | 6.5 | 6.5 |
| Docetaxel | 23 | 6.5 | 6.5 |